| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Calidi Biotherapeutics, Inc. | Chief Scientific Officer | Stock Options (right to buy) | 35,000 | 03 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLDI | Calidi Biotherapeutics, Inc. | 03 Sep 2025 | 1 | $0 | 4 | Chief Scientific Officer | 05 Sep 2025, 19:56 |
| CLDI | Calidi Biotherapeutics, Inc. | 12 Sep 2023 | 0 | $0 | 3 | SVP, Global Head of R&D | 25 Sep 2023, 18:39 |